RIPK3 and chronic kidney disease: RIPK3-MLKL-mediated tubular loss and necroinflammation also contribute to CKD progression in rats that have undergone subtotal nephrectomy (Zhu et al., 2016) and AKI-to-CKD transition in a mouse IRI model (Chen et al., 2018).